REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 188 filers reported holding REPLIGEN CORP in Q4 2017. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,938,706 | -4.8% | 181,993 | -15.3% | 0.00% | 0.0% |
| Q2 2023 | $30,382,072 | -13.5% | 214,775 | +3.0% | 0.00% | -25.0% |
| Q1 2023 | $35,112,862 | +86106.7% | 208,557 | -13.3% | 0.00% | -20.0% |
| Q4 2022 | $40,731 | -99.9% | 240,576 | -2.8% | 0.01% | -28.6% |
| Q3 2022 | $46,306,000 | +9.6% | 247,478 | -4.8% | 0.01% | +16.7% |
| Q2 2022 | $42,234,000 | -12.1% | 260,071 | +1.8% | 0.01% | 0.0% |
| Q1 2022 | $48,065,000 | -34.3% | 255,545 | -7.5% | 0.01% | -25.0% |
| Q4 2021 | $73,155,000 | -18.9% | 276,223 | -11.6% | 0.01% | -27.3% |
| Q3 2021 | $90,254,000 | +82.0% | 312,310 | +25.7% | 0.01% | +83.3% |
| Q2 2021 | $49,599,000 | -49.5% | 248,466 | -50.8% | 0.01% | -53.8% |
| Q1 2021 | $98,222,000 | +49.0% | 505,240 | +46.8% | 0.01% | +30.0% |
| Q4 2020 | $65,938,000 | +188.2% | 344,086 | +126.5% | 0.01% | +150.0% |
| Q3 2020 | $22,879,000 | +2.2% | 151,925 | -16.1% | 0.00% | 0.0% |
| Q2 2020 | $22,390,000 | +101.5% | 181,132 | +57.4% | 0.00% | +33.3% |
| Q1 2020 | $11,111,000 | +41.3% | 115,073 | +35.4% | 0.00% | +200.0% |
| Q4 2019 | $7,863,000 | +64.8% | 85,015 | +36.6% | 0.00% | 0.0% |
| Q3 2019 | $4,771,000 | -7.5% | 62,217 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $5,156,000 | +609.2% | 61,509 | +400.2% | 0.00% | – |
| Q1 2019 | $727,000 | +2.8% | 12,298 | -8.2% | 0.00% | – |
| Q4 2018 | $707,000 | -12.2% | 13,399 | -7.7% | 0.00% | – |
| Q3 2018 | $805,000 | +3.5% | 14,519 | -12.2% | 0.00% | – |
| Q2 2018 | $778,000 | +32.3% | 16,530 | +1.6% | 0.00% | – |
| Q1 2018 | $588,000 | -29.6% | 16,272 | -29.3% | 0.00% | – |
| Q4 2017 | $835,000 | +235.3% | 23,018 | +248.7% | 0.00% | – |
| Q3 2017 | $249,000 | +33.2% | 6,601 | +46.2% | 0.00% | – |
| Q2 2017 | $187,000 | +40.6% | 4,514 | +20.2% | 0.00% | – |
| Q1 2017 | $133,000 | +51.1% | 3,755 | +31.9% | 0.00% | – |
| Q4 2016 | $88,000 | +63.0% | 2,847 | +58.2% | 0.00% | – |
| Q3 2016 | $54,000 | +5300.0% | 1,800 | +4086.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | -97.0% | 43 | -96.3% | 0.00% | – |
| Q4 2015 | $33,000 | -99.0% | 1,171 | -98.6% | 0.00% | -100.0% |
| Q2 2015 | $3,455,000 | +838.9% | 83,747 | +418.9% | 0.00% | – |
| Q2 2014 | $368,000 | – | 16,139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |